Michael S. Torbenson
#148,490
Most Influential Person Now
Michael S. Torbenson's AcademicInfluence.com Rankings
Michael S. Torbensonphilosophy Degrees
Philosophy
#8094
World Rank
#11412
Historical Rank
Logic
#5125
World Rank
#6495
Historical Rank
Michael S. Torbensonbiology Degrees
Biology
#10931
World Rank
#14296
Historical Rank
Pathology
#145
World Rank
#269
Historical Rank
Download Badge
Philosophy Biology
Michael S. Torbenson's Degrees
- Doctorate Medicine University of Pennsylvania
- PhD Pathology University of Pennsylvania
Why Is Michael S. Torbenson Influential?
(Suggest an Edit or Addition)Michael S. Torbenson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease (2005) (8022)
- The Immune Landscape of Cancer (2018) (2766)
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model (2009) (1722)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (2017) (1514)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal (2013) (1148)
- Occult hepatitis B. (2002) (540)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
- Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. (2011) (416)
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma (2011) (405)
- Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. (2004) (364)
- Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (2017) (361)
- mTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms (2004) (359)
- New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver Cancer (2006) (318)
- MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 (2009) (273)
- Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. (2006) (268)
- Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. (2002) (267)
- Preoperative Chemotherapy for Colorectal Liver Metastases: Impact on Hepatic Histology and Postoperative Outcome (2007) (247)
- Role of liver biopsy in management of chronic hepatitis C: A systematic review (2002) (245)
- Dietary Composition and Nonalcoholic Fatty Liver Disease (2004) (227)
- Chronic intermittent hypoxia predisposes to liver injury (2007) (217)
- Long interspersed element-1 protein expression is a hallmark of many human cancers. (2014) (210)
- Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. (2012) (207)
- Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults (2007) (202)
- Glycogenic Hepatopathy: An Underrecognized Hepatic Complication of Diabetes Mellitus (2006) (201)
- &bgr;-Catenin Immunohistochemistry Separates Mesenteric Fibromatosis From Gastrointestinal Stromal Tumor and Sclerosing Mesenteritis (2002) (194)
- Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus (2005) (190)
- Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. (2006) (190)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
- Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. (2007) (184)
- Role for Hedgehog signaling in hepatic stellate cell activation and viability (2005) (178)
- Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity (2003) (177)
- Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. (2003) (177)
- Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. (2009) (177)
- Exercise Prevents Diet-Induced Cellular Senescence in Adipose Tissue (2016) (171)
- Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. (2001) (163)
- Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases (2013) (161)
- Hepatic fibrogenesis requires sympathetic neurotransmitters (2004) (160)
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review (2002) (153)
- Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. (2009) (146)
- Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic (2006) (145)
- Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. (2007) (141)
- Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. (2003) (135)
- The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection (2005) (128)
- Treatment of chronic hepatitis C: A systematic review (2002) (126)
- Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma: Initial Experience in the United States (2009) (125)
- A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. (2008) (122)
- Hepatitis B Virus Replication Induces Methylation of both Host and Viral DNA (2010) (121)
- Review of the Clinicopathologic Features of Fibrolamellar Carcinoma (2007) (120)
- DNAJB1-PRKACA is specific for fibrolamellar carcinoma (2015) (119)
- The impact of ethnicity on the natural history of autoimmune hepatitis (2007) (119)
- Malignant transformation of hepatic adenomas (2008) (118)
- Sevelamer Crystals in the Gastrointestinal Tract (GIT): A New Entity Associated With Mucosal Injury (2013) (115)
- Progression of liver fibrosis among injection drug users with chronic hepatitis C (2006) (114)
- Tuberculosis-associated haemophagocytic syndrome. (2006) (113)
- High prevalence of occult hepatitis B in Baltimore injection drug users (2004) (109)
- Autoimmune Gastritis: Distinct Histological and Immunohistochemical Findings Before Complete Loss of Oxyntic Glands (2002) (105)
- Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. (2012) (104)
- MicroRNA down‐regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint (2011) (104)
- Non‐alcoholic fatty liver disease contributes to hepatocarcinogenesis in non‐cirrhotic liver: A clinical and pathological study (2013) (101)
- Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. (2002) (101)
- Fibrolamellar Carcinomas are Positive for CD68 (2010) (97)
- Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs (2014) (97)
- Diffusion-weighted Magnetic Resonance Imaging for the Staging of Liver Fibrosis (2011) (93)
- Methylation regulates hepatitis B viral protein expression. (2009) (92)
- Fibrolamellar Carcinoma: 2012 Update (2012) (91)
- Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel (2017) (90)
- STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. (2002) (89)
- Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. (2008) (89)
- Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033)) (2017) (88)
- Hepatic Adenomas: Analysis of Sex Steroid Receptor Status and the Wnt Signaling Pathway (2002) (86)
- Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3 (2011) (85)
- Hepatitis B viral DNA is methylated in liver tissues (2007) (84)
- Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. (2013) (83)
- Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury (2003) (83)
- Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. (2013) (82)
- Severity and correlates of liver disease in hepatitis C virus–infected injection drug users (2002) (81)
- Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. (2008) (79)
- Morphologic Subtypes of Hepatocellular Carcinoma. (2017) (79)
- Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. (2006) (78)
- Primary liver carcinoma arising in people younger than 30 years. (2005) (78)
- High‐fat diet modulates non‐CD1d‐restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis (2007) (77)
- Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct. (2020) (74)
- Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein. (2016) (74)
- Sporadic Fundic Gland Polyposis: A Clinical, Histological, and Molecular Analysis (2002) (72)
- Atrophic Autoimmune Pangastritis: A Distinctive Form of Antral and Fundic Gastritis Associated With Systemic Autoimmune Disease (2006) (71)
- Causes of death in autopsied liver transplantation patients. (1998) (70)
- Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma (2013) (70)
- MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. (2012) (70)
- A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer (2012) (68)
- Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. (2003) (66)
- Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases (2016) (65)
- Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma (2017) (64)
- Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration (2008) (63)
- Unique conformation of cancer autoantigen B23 in hepatoma: A mechanism for specificity in the autoimmune response (2003) (62)
- Collagenous colitis with mucosal tears on endoscopic insufflation: a unique presentation (2002) (61)
- Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma (2015) (61)
- Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. (2017) (61)
- Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways. (2007) (61)
- Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation (2005) (60)
- Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. (2009) (59)
- Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma (2014) (59)
- Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category. (2014) (59)
- Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery (2006) (58)
- Breath biomarkers and non-alcoholic fatty liver disease: Preliminary observations (2006) (57)
- Liver cancer biopsy – back to the future?! (2015) (57)
- Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma. (2015) (57)
- Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution (2009) (57)
- Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea. (2015) (55)
- Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification (2013) (55)
- Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. (2007) (54)
- Pathology of the liver sinusoids (2014) (54)
- Mitochondrial Mutations in Hepatocellular Carcinomas and Fibrolamellar Carcinomas (2009) (53)
- Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. (2011) (51)
- Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers (2010) (50)
- ARID2: A new tumor suppressor gene in hepatocellular carcinoma (2011) (50)
- An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa‐2b combination therapy for chronic hepatitis C (2009) (49)
- Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. (2005) (49)
- Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. (2003) (48)
- Bile Duct Dysplasia in the Setting of Chronic Hepatitis C and Alcohol Cirrhosis (2007) (48)
- Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten‐free diet (2017) (48)
- Colonic spirochetosis in children and adults. (2003) (48)
- Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature. (1998) (48)
- Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer. (2007) (47)
- EGFR is phosphorylated at Ty845 in hepatocellular carcinoma (2006) (46)
- Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists. (2012) (45)
- Detection of Tumor DNA at the Margins of Colorectal Cancer Liver Metastasis (2011) (45)
- Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features (2013) (44)
- Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1‐PRKACA fusion (2018) (44)
- Clinical implications of basic research in hepatocellular carcinoma. (2016) (43)
- Bile Ducts and Ductules Are Positive for CD56 (N-CAM) in Most Cases of Extrahepatic Biliary Atresia (2003) (43)
- Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer. (2005) (43)
- A broad survey of cathepsin K immunoreactivity in human neoplasms. (2013) (42)
- Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection (2004) (42)
- Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration (2009) (42)
- Reticulin Loss in Benign Fatty Liver: An Important Diagnostic Pitfall When Considering a Diagnosis of Hepatocellular Carcinoma (2012) (42)
- Hepatocellular Carcinomas Show Abnormal Expression of Fibronectin Protein (2002) (42)
- Hepatic Adenomas: Classification, Controversies, and Consensus. (2018) (41)
- Isoosmolar enemas demonstrate preferential gastrointestinal distribution, safety, and acceptability compared with hyperosmolar and hypoosmolar enemas as a potential delivery vehicle for rectal microbicides. (2013) (41)
- Molecular testing for the clinical diagnosis of fibrolamellar carcinoma (2017) (41)
- Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Colon After Simulated Receptive Anal Intercourse in Men Who Have Sex With Men (2012) (40)
- Glycogen Pseudoground Glass Change in Hepatocytes (2006) (40)
- PEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion. (2007) (39)
- Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice (2015) (39)
- Relation Between Vitamin D Status and Nonalcoholic Fatty Liver Disease in Children (2015) (39)
- Neonatal Giant Cell Hepatitis: Histological and Etiological Findings (2010) (39)
- Selenium Supplementation Decreases Hepatic Fibrosis in Mice After Chronic Carbon Tetrachloride Administration (2009) (38)
- Immunostaining of plasma cells in primary biliary cirrhosis. (2009) (38)
- Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas (2008) (37)
- Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice (2009) (37)
- Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. (2013) (37)
- Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma (2013) (36)
- Pigmented hepatocellular adenomas have a high risk of atypia and malignancy (2015) (35)
- Arginase-1 is frequently positive in hepatoid adenocarcinomas. (2016) (35)
- Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). (2000) (35)
- Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study. (2015) (34)
- Contribution of higher risk genes and European admixture to Crohn's disease in African Americans (2012) (32)
- Progression of Fibrosis during Chronic Hepatitis C Is Associated with Rapid Virus Evolution (2007) (32)
- Hepatitis in common variable immunodeficiency. (2009) (31)
- Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling. (2002) (30)
- Uterine Tumor Resembling Ovarian Sex Cord Tumor: Report of a Case With t(X;6)(p22.3;q23.1) and t(4;18)(q21.1;q21.3) (2003) (30)
- Hepatocellular Neoplasms Arising in Association With Androgen Use (2016) (29)
- Misuse of scoring systems (2011) (29)
- Hepatic angiomyolipoma and hepatic stellate cells share a similar gene expression profile. (2005) (29)
- Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. (2011) (28)
- Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens (2000) (28)
- The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography. (2010) (28)
- Concurrent Evaluation of p53, β-Catenin, and α-Fetoprotein Expression in Human Hepatocellular Carcinoma (2004) (28)
- Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings. (2017) (26)
- Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B. (2013) (26)
- Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection (2008) (26)
- Primary Hepatic Tumors With Myxoid Change: Morphologically Unique Hepatic Adenomas and Hepatocellular Carcinomas (2015) (26)
- Hepatocellular Carcinoma: Making Sense of Morphological Heterogeneity, Growth Patterns, and Subtypes. (2020) (23)
- Globular Hepatic Amyloid Is Highly Sensitive and Specific for LECT2 Amyloidosis (2015) (23)
- Leiomyosarcoma of the breast: a pathologic and comparative genomic hybridization study of two cases. (2004) (23)
- Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas (2016) (23)
- 160 Design and validation of a histologic scoring system for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) (2003) (23)
- Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization. (2010) (22)
- Clinical, Biochemical, and Histopathology Features of Patients With Glycogenic Hepatopathy (2017) (21)
- Standardising the interpretation of liver biopsies in non‐alcoholic fatty liver disease clinical trials (2019) (21)
- MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis. (2013) (21)
- Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases (2018) (21)
- FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. (2011) (21)
- Hamartomas and malformations of the liver. (2019) (20)
- Sirolimus Monotherapy Versus Sirolimus in Combination with Steroids and/or MMF for Immunosuppression After Liver Transplantation (2006) (20)
- Marked Iron in Liver Explants in the Absence of Major Hereditary Hemochromatosis Gene Defects: A Risk Factor for Cardiac Failure (2009) (19)
- A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative. (2017) (19)
- Angiosarcoma of the Liver: Clinicopathologic Features and Morphologic Patterns (2019) (19)
- Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma (2016) (19)
- Hyperplastic Luschka Ducts: A Mimic of Adenocarcinoma in the Gallbladder Fossa (2011) (19)
- Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection. (2003) (19)
- Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma. (2004) (18)
- Occurrence of a multimeric high-molecular-weight glyceraldehyde-3-phosphate dehydrogenase in human serum. (2015) (18)
- Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient Derived Xenografts and Direct from Patient Screening. (2021) (18)
- HFE mutations in α-1-antitrypsin deficiency: an examination of cirrhotic explants (2010) (18)
- 18O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma (2008) (18)
- Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss (2016) (17)
- Inflammatory pseudotumor of the liver. (2005) (17)
- Lash’s: A bitter medicine: Biochemical analysis of an historical proprietary medicine (2000) (17)
- Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C‐infected drug users (2012) (17)
- Segmental Atrophy of the Liver: A Distinctive Pseudotumor of the Liver With Variable Histologic Appearances (2011) (16)
- Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfall. (2017) (16)
- Vitamin D Deficiency and Its Relation to Bone Mineral Density and Liver Fibrosis in HIV–HCV Coinfection (2013) (16)
- The Almost-Normal Liver Biopsy: Presentation, Clinical Associations, and Outcome (2017) (16)
- Use of T-Cell Antibodies for Donor Dosaging in a Canine Model of in utero Hematopoietic Stem Cell Transplantation (2007) (16)
- De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B. (2005) (15)
- OCCULT HEPATITIS B INFECTION (2002) (15)
- Cytopathologic grading of hepatocellular carcinoma on fine‐needle aspiration (2004) (15)
- Unmet needs and new models for future trials in autoimmune hepatitis. (2018) (15)
- The Full Spectrum of Hepatic Steatosis in Children (2015) (14)
- Pathology of liver disease: advances in the last 50years. (2019) (14)
- Assessing liver fibrosis: Comparison of arterial enhancement fraction and diffusion‐weighted imaging (2014) (14)
- Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine (2020) (13)
- Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates. (2015) (13)
- Hepatic tumors of vascular origin: imaging appearances (2018) (13)
- Biopsy interpretation of the liver (2014) (13)
- Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials (2014) (13)
- Treponema pallidum Immunohistochemistry is positive in human intestinal Spirochetosis (2018) (13)
- OCCULT NONHEMATOPOIETIC MALIGNANCIES PRESENT AT AUTOPSY IN SOLID ORGAN TRANSPLANT PATIENTS WHO DIED WITHIN 100 DAYS (2001) (12)
- Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field. (2007) (12)
- Knowledge gaps in the appendix: a multi-institutional study from seven academic centers (2019) (12)
- Khat chewing and cirrhosis in Somaliland: Case series (2016) (12)
- FHIT mRNA and protein expression in hepatocellular carcinoma (2004) (11)
- Colchicine effect in a colonic hyperplastic polyp. A lesion mimicking serrated adenoma. (2002) (11)
- Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. (2007) (11)
- FGFR1 and FGFR2 in fibrolamellar carcinoma (2016) (11)
- Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States. (2008) (10)
- String-Like Micellar Nanoparticles Formed by Complexation of PEG-b-PPA and Plasmid DNA and Their Transfection Efficiency (2011) (10)
- Immunohistochemistry and Special Stains in Medical Liver Pathology. (2017) (10)
- Renal cortical neoplasms in long term survivors of solid organ transplantation. (2000) (10)
- The role of Magnetic Resonance Elastography in the Diagnosis of Non-Cirrhotic Portal Hypertension. (2020) (10)
- Etiology of cirrhosis in the young. (2019) (10)
- Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons (2010) (9)
- Anastomosing hemangioma of the liver: a case series (2019) (9)
- Histology of Symptomatic Acute Hepatitis C Infection in Immunocompetent Adults (2007) (9)
- In utero Hematopoietic Stem Cell Transplantation in Canines: Exploring the Gestational Age Window of Opportunity to Maximize Engraftment (2013) (9)
- Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant (2016) (9)
- Colonic Adenomatous Polyps Involving Submucosal Lymphoglandular Complexes: A Diagnostic Pitfall (2018) (9)
- Hepatitis B Virus-Associated Hepatocellular Carcinoma from India: Role of Viral Genotype and Mutations in CTNNB1 (Beta-Catenin) and TP53 Genes (2011) (9)
- The Utility of MR Elastography to Differentiate Nodular Regenerative Hyperplasia from Cirrhosis (2018) (9)
- Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma (2017) (8)
- [Current aspects of liver allograft pathology]. (2011) (8)
- PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga (2021) (8)
- Epigenetic Regulation of Hepatitis B Virus Infection (2011) (8)
- Identification of key challenges in liver pathology: data from a multicenter study of extramural consults. (2019) (7)
- Morphologic and Molecular Findings in Myxoid Hepatic Adenomas (2021) (7)
- Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis (2019) (7)
- Role of liver biopsy in management of chronic hepatitis C: A systematic review (2002) (7)
- Immunohistochemical pitfalls in the diagnosis of hepatocellular adenomas and focal nodular hyperplasia: accurate understanding of diverse staining patterns is essential for diagnosis and risk assessment (2015) (6)
- 5 – Disorders of iron overload (2012) (6)
- Arcuate and interlobular phlebitis in renal allografts. (2001) (6)
- Intracranial metastasis in fibrolamellar hepatocellular carcinoma (2018) (6)
- Punctured Human Bones of the Laurel Culture from Smith Mound Four, Minnesota (1992) (6)
- Non-neoplastic and neoplastic disorders of the appendix (2012) (6)
- Environmental exposures as a risk factor for fibrolamellar carcinoma (2017) (6)
- Well-differentiated hepatocellular neoplasm of uncertain malignant potential--reply. (2015) (6)
- Hepatocellular Neoplasms Arising in Genetic Metabolic Disorders: Steatosis is Common in Both Tumor and Background Liver. (2020) (5)
- Human remains from McKinstry mound two (1996) (5)
- Pediatric Hepatocellular Adenomas (2021) (5)
- Surgical Pathology of Liver Tumors. (2016) (5)
- Biopsies of Hepatocellular Carcinoma with no Reticulin Loss: An Important Diagnostic Pitfall. (2020) (5)
- Rapid Fibrosis Progression Among HIV/Hepatitis C Virus (HCV) Coinfected Adults: Prospective Analysis of 446 Liver Biopsy Pairs (2011) (5)
- Management of chronic hepatitis C. (2002) (5)
- Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia (2021) (4)
- Hepatic segmental atrophy and nodular elastosis: imaging features (2017) (4)
- Ki-67 “hot spot” digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomas (2020) (4)
- Concurrent increase in mitosis and apoptosis: a histological pattern of hepatic arterial flow abnormalities in post-transplant liver biopsies (2012) (4)
- Aberrant keratin expression is common in primary hepatic malignant vascular tumors: A potential diagnostic pitfall. (2020) (4)
- Fibrolamellar hepatocellular carcinoma: Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosis (2017) (4)
- Juxta-caval hepatic angiomyolipoma masquerading as hepatocellular carcinoma. (2003) (4)
- Tumors of the liver (2018) (3)
- Concurrent Evaluation of p 53 , β-Catenin , and α-Fetoprotein Expression in Human Hepatocellular Carcinoma (2004) (3)
- Morphological heterogeneity in beta-catenin mutated hepatocellular carcinomas: implications for tumor molecular classification. (2021) (3)
- Hedgehog signaling correlates with hepatocellular carcinoma progression (2005) (3)
- Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma (2020) (3)
- Emerging causes of morbidity and mortality in organ transplant patients (2006) (3)
- Human liver organoids for disease modeling of fibrolamellar carcinoma (2022) (3)
- SULF2 monoclonal antibody 5D5 suppresses human cholangiocarcinoma xenograft growth via regulation of a SULF2-PDGFRβ-YAP signaling axis. (2021) (3)
- Steatohepatitic hepatocellular carcinoma (2021) (3)
- 3 Developmental and Inherited Liver Disease (2018) (3)
- Iron in the Liver: A Review for Surgical Pathologists (2011) (3)
- An unusual polyp: a pedunculated leiomyoma of the sigmoid colon. (2011) (3)
- Treatment of chronic hepatitis C: A systematic review (2002) (3)
- A quantitative profile of the patent medicine industry in Baltimore from 1863 to 1930. (2007) (3)
- Laurel Culture Human Remains From Smith Mounds Three and Four (1994) (3)
- Liver fibrosis quantification (2022) (3)
- CPA1 and REG1a as New Markers for Pancreatic Acinar Cell Carcinoma. (2020) (3)
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review (2002) (3)
- Erratum to "Clinical implications of basic research in hepatocellular carcinoma" [J Hepatol 2016;64:736-745]. (2016) (2)
- Lash's bitters: From the bathroom to the barroom (2001) (2)
- Incidence and prognostic impact of KRAS and BRAF mutations in patients undergoing liver surgery for colorectal metastases. (2012) (2)
- Amyloid-like Fibronectin Deposits in the Liver (2020) (2)
- Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations (2022) (2)
- Hepatocellular Neoplasms with Loss of Liver Fatty Acid Binding Protein: Clinicopathologic Features and Molecular Profiling. (2022) (2)
- Transgenic hepatitis B: a new model of HBV infection (2017) (2)
- Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury (2009) (2)
- Co-expression of CDX2 and CK20 in hepatocellular carcinoma, an exceedingly rare co-incidence with potential diagnostic pitfall-reply. (2018) (2)
- Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2–Platelet‐Derived Growth Factor Receptor Beta–Yes‐Associated Protein Signaling Axis (2021) (2)
- MR elastography in primary sclerosing cholangitis: a pictorial review (2022) (2)
- Desmoid Tumor. (2018) (2)
- Phenotypic and genotypic differences between a child with vertically acquired severe hepatitis C liver disease and his mother. (2012) (2)
- Common Types of Gastritis (2019) (2)
- Prevalence of Alternative Lengthening of Telomeres ( ALT ) in Human Cancer Subtypes (2011) (1)
- Clinical and demographic predictors of survival for fibrolamellar carcinoma patients—A patient community, registry‐based study (2022) (1)
- Successful treatment of severe refractory hepatic graft-versus-host disease by cadaveric liver transplant (2013) (1)
- Fibrolamellar Carcinoma: Diagnosis and Diagnostic Pitfalls (2014) (1)
- Diagnostic approach to well-differentiated hepatocellular carcinoma (2021) (1)
- Advances in Brief Novel Therapy for Liver Cancer : Direct Intraarterial Injection of a Potent Inhibitor of ATP Production 1 (2002) (1)
- Hemangiomas and Other Vascular Tumors (2020) (1)
- 349 Hepatic fibrogenesis requires sympathetic neurotransmitters (2003) (1)
- Regenerative Hepatic Pseudotumor: A New Pseudotumor of the Liver. (2020) (1)
- Clinical/pathologic features and survival of patients with fibrolamellar-hepatocellular carcinoma (FLL-HCC): Data from the Fibrolamellar-Hepatocellular (FLL-HCC) Consortium. (2011) (1)
- Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation (2022) (1)
- Benign Hepatic Lesions Arising in Accessory Hepatic Lobes (2018) (1)
- 4 – Disorders of Iron Overload (2018) (1)
- 236 Independent Validation of the Safe Biopsy Algorithm: Analysis of the Achieve Cohorts (2010) (1)
- DNAJB1‐PRKACA–positive metastatic fibrolamellar carcinoma with unknown primary in a pediatric patient (2019) (1)
- A case study of the Lash's Bitters company - Advertising changes after the Federal Food and Drugs Act of 1906 and the Sherley Amendment of 1912. (2003) (1)
- A Pyruvic Acid Analog Primarily Targets GAPDH To Promote Cancer Cell Death (2009) (1)
- Imaging Features in the Liver after Stereotactic Body Radiation Therapy. (2022) (1)
- 734 Dietary composition and fatty liver disease (2003) (1)
- Evaluation and Management of Liver Masses (2020) (1)
- Concurrent Versus Sequential Sorafenib Therapy in Combination With Radiation for Hepatocellular Carcinoma: A Preclinical Study (2012) (0)
- Abstract 1469: Radiosensitization of hepatocellular carcinoma using rationally combined molecular-targeted agents (2012) (0)
- Abstract No. 165: [R/F] Distribution of Iron Oxide Embospheres after TAE in the Vx-2 Liver Tumor: Evaluation with MR Imaging and Pathology (2008) (0)
- Methylation of Both Host and Viral DNA (2010) (0)
- 416 LONGITUDINAL PROSPECTIVE COMPARISON OF FIBROSURE AND TRANSIENT ELASTOGRAPHY IN RELATION TO VIROLOGIC RESPONSE: A SUBSTUDY OF THE PHASE 3 ALBINTERFERON ALFA-2B TRIALS (2010) (0)
- Problems and Solutions: A special issue of gastrointestinal, pancreatic, and liver pathology. (2022) (0)
- Abstract No. 218: In-Vivo Evaluation of Different Calibrated Spherical PVA Microspheres for TACE (2008) (0)
- 3-Bromopyruvate Blocks Energy Metabolism and Liver Cancer (2004) (0)
- 348 Norepinephrine induces hepatic fibrogenesis in leptin deficient OB/OB mice (2003) (0)
- Lack of association of endemic H. pylori gastritis with gastric carcinoma (2000) (0)
- The Role of Kinase Fusion DNAJB1-PRKACA in Fibrolamellar Hepatocellular Carcinoma (2017) (0)
- 1073 Micro-RNA 21 Is Overexpressed and Can Accurately Diagnose Human Cholangiocarcinoma (2009) (0)
- 101. Development of an analytical pipeline for detecting fusions of clinical relevance in liver cancer (2022) (0)
- neurotransmitters Hepatic fibrogenesis requires sympathetic (2008) (0)
- Tu1837 Full Spectrum View of Pediatric Liver Steatosis (2014) (0)
- 306 RELATION OF INSULIN RESISTANCE AND HEPATIC STEATOSIS WITH ADVANCED HEPATIC FIBROSIS IN PATIENTS WITH GENOTYPE 1 OR 2/3 CHRONIC HEPATITIS C (2010) (0)
- Colchicine Effect in a Colonic Hyperplastic Polyp (2009) (0)
- FibroSURE TM and FibroScan ® in relation to treatment response in chronic hepatitis C virus (2011) (0)
- Biopsy Interpretation of the Liver (Biopsy Interpretation Series) (2014) (0)
- Non-Neoplastic Diseases of the Liver (2022) (0)
- Clinical and Histological Predictors of Discordance Between the Fibrotest and Fibroscan: Analysis of the Achieve Cohorts (2010) (0)
- CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus (2011) (0)
- Autoimmune Gastritis: An Underappreciated Entity (2019) (0)
- 806 Etiology of Cirrhosis in the Young (2015) (0)
- Fibrolamellar Carcinoma (2020) (0)
- Hemochromatosis. (2022) (0)
- response in chronic hepatitis C virus (2011) (0)
- Abstract No. 162: Quantification of Tumor Necrosis Using Functional MR Imaging with Pathologic Correlation in Rabbits with Vx-2 Tumors (2008) (0)
- RENAL ALLOGRAFT OUTCOME IS PREDICTED BY BANFF HISTOLOGIC GRADES OF TUBULITIS AND INTIMAL ARTERITIS.: Abstract# 436 Poster Board #‐Session: P76‐II (2000) (0)
- 1084 INDEPENDENT VALIDATION OF THE SAFE BIOPSY ALGORITHM: ANALYSIS OF THE ACHIEVE COHORTS (2010) (0)
- Disease proteomics (2009) (0)
- Development of a Dietary Methyl Donor Food Frequency Questionnaire to Assess Folate and Vitamin B12 Status in Children with Chronic Hepatitis B Virus Infection (2018) (0)
- In utero hematopoietic stem cell transplantation in canines: The gestational window of opportunity to maximize engraftment (2005) (0)
- 431 A Novel MicroRNA Panel Accurately Diagnoses Cholangiocarcinoma Using Nearest Shrunken Centroids (2008) (0)
- Primary Neuroendocrine Tumors and Primary Neuroendocrine Carcinomas of the Liver: A Proposal for a Multidiscipline Definition. (2022) (0)
- Nonneoplastic Diseases of the Stomach (2020) (0)
- Alternative Lengthening of Telomeres in Primary Hepatic Neoplasms. (2022) (0)
- The Rodger C. Haggitt Gastrointestinal Pathology Society at the 2020 United States and Canadian Academy of Pathology: A Mini-symposium. (2021) (0)
- Smoothened overexpression activates hedgehog signaling in human hepatocarcinogenesis (2006) (0)
- Glycogen Pseudoground Glass Hepatocellular Inclusions in Cystic Fibrosis Patients (2016) (0)
- Hepatocellular Carcinoma (2020) (0)
- Eosinophilic Disorders of the Gastrointestinal Tract and Associated Abdominal Viscera: Imaging Findings and Diagnosis. (2022) (0)
- Fifty years of impact on liver pathology: a history of the Gnomes (2020) (0)
- Hepatic Focal Nodular Hyperplasia. (2020) (0)
- Surface color spectrophotometry in a murine model of steatosis: an accurate technique with potential applicability in liver procurement (2021) (0)
- High prevalence of occult hepatitis B in a cohort of IV drug users (2003) (0)
- Benign Pediatric Liver Tumors (2015) (0)
- Transgenic hepatitis B: a new model of HBV infection (2017) (0)
- Microchimerism following canine in utero hematopoietic stem cell transplantation: Development of T-cell dosing regimens (2004) (0)
- Selling the Cure: Images of Health and Disease in Early American Patent Medicine Advertisements (2007) (0)
- Rare Liver Tumors (2020) (0)
- Human Cancer Biology Detection of Tumor DNA at the Margins of Colorectal Cancer Liver Metastasis (2011) (0)
- Abstract No. 142: Single centre phase II trial of transarterial chemoembolization with drug eluting beads for patients with unresectable hepatocellular carcinoma: Initial experience in the USA (2010) (0)
- Comprar Biopsy Interpretation of the Liver | Michael Torbenson | 9781451182576 | Lippincott Williams & Wilkins (2014) (0)
- Integrative Genomic Analy sis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles Graphical (2017) (0)
- The Almost-normal Liver Biopsy (2017) (0)
- Single Cell Laser Capture Microdissection Reveals the Hepatitis C Viral Landscape in the Human Liver (2012) (0)
- Man With Fever and Severe Diarrhea. (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael S. Torbenson?
Michael S. Torbenson is affiliated with the following schools:
